Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-08-03
Item 8.01
The filing discloses the closing of a material sale of two business units (Percocet and Endocet) to Par Health, Inc. for approximately $250 million in total consideration ($25 million upfront plus five years of earnout payments). This constitutes a material disposition/divestiture that fundamentally alters the company's business scope—the company explicitly states it will "no longer market, manufacture or distribute opioid products" following completion. This is a completed M&A transaction requiring disclosure under Item 1.02 or 2.01 standards, disclosed here under Item 8.01.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This exhibit discloses Fresenius Medical Care's Q2 2026 financial results, reporting operating income excluding special items of EUR 569 million (up 23% at constant currency) and group revenue of EUR 4,861 million (up 4% at constant currency), both exceeding market consensus expectations. The company also confirms its full-year 2026 outlook. This is a discrete earnings announcement for a quarterly period, material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.1
This is a press release disclosing Fresenius Medical Care's Q2 2026 financial results, including revenue of EUR 4,861 million, operating income growth of 23% (adjusted), and EPS growth of 28% (adjusted). The document explicitly presents quarterly earnings figures, segment performance, cash flow metrics, and reaffirms the FY 2026 outlook—all hallmarks of an earnings release. Material to investors assessing the company's financial performance and strategic progress.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-03
EX-99.1
The press release announces the appointment of Cassie McLean as a member of the Management Board and Chief Executive Officer of the Care Delivery operating segment, effective August 1, 2026. This is a material executive appointment to a senior leadership role at a major global healthcare company. The disclosure also notes that Craig Cordola, the previous CEO of Care Delivery, has departed from that role, but the principal disclosed action is McLean's appointment to the Management Board.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Matson, Inc. issued a press release on August 3, 2026 announcing second quarter 2026 earnings results, including net income of $129.4 million ($4.27 per diluted share), consolidated operating income of $158.9 million, and consolidated revenue of $969.4 million. The company also raised its full-year 2026 outlook. This is a standard quarterly earnings disclosure under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-03
Item 8.01
Kinder Morgan entered into an underwriting agreement on July 28, 2026 to issue $1.15 billion of 5.550% Senior Notes due 2036 and $600 million of 6.150% Senior Notes due 2056, totaling $1.75 billion in new debt obligations. The filing discloses the material terms, interest rates, maturity dates, and intended use of proceeds for debt repayment and refinancing. This is a clear debt issuance event material to investors assessing the company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Vertex issued a press release on August 3, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing total revenues of $204.0 million (up 10.5% YoY), adjusted EBITDA of $51.0 million, and net income of $9.0 million, along with forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 95%
filed 2026-08-03
Item 7.01
QVC Group, Inc. filed voluntary Chapter 11 petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for the period ended June 30, 2026, which is a mandatory filing requirement under the Bankruptcy Code. The filing shows total liabilities of $1.39 billion against total assets of $299 million, resulting in a deficit of $1.09 billion. This is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 7.01
Jackson Financial Inc. has furnished a slide presentation for its second quarter 2026 earnings call scheduled for August 4, 2026. The presentation discloses key financial results including GAAP earnings of $644M, non-GAAP earnings of $513M, earnings per share of $9.16 (GAAP) and $7.30 (non-GAAP), free cash flow of $287M, and capital return of $290M. This is a standard earnings release disclosure under Item 7.01 (Regulation FD Disclosure), with the detailed financial results and metrics presented in Exhibit 99.1.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 95%
filed 2026-08-03
Item 7.01
QVC Inc. and its affiliates filed voluntary Chapter 11 petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for the period ended June 30, 2026, as required by the Bankruptcy Code. The filing itself—a Chapter 11 bankruptcy—is a terminal event materially threatening the registrant's continued existence and was previously disclosed in an April 16, 2026 8-K. This current disclosure updates investors on the company's financial condition during bankruptcy proceedings, showing cumulative losses of $61.7 million and negative equity of $5.4 billion as of June 30, 2026.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-03
Item 5.02
The disclosure centers on amendments to Mark Penn's (CEO) employment agreement and a new stock appreciation rights grant. The Amendment increases his base salary from $1,260,000 to $1,400,000, sets his bonus target at 240% of base salary, establishes a long-term equity incentive target of 450% of base salary, and grants 2,000,000 SARs with a base price of $8.45 per share vesting over three years. This is a compensatory arrangement disclosure under Item 5.02(e), not a departure or appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-03
Item 5.02
Matthew Whitlock was appointed as Chief Investment Officer of Chiron Real Estate Inc. and Inter-American Management LLC effective August 3, 2026. The disclosure details his appointment, employment agreement with $400,000 base salary, equity inducement awards valued at $350,000, and severance provisions. While the section also describes Alfonzo Leon's transition from CIO to Strategic Advisor, the principal disclosed action centers on Whitlock's appointment to a senior executive role with substantial compensation and equity arrangements, making this an executive appointment event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-03
Item 8.01
The filing discloses Supernus's entry into an agreement to combine with Indivior Pharmaceuticals in an all-stock "merger of equals" to create a leading U.S. biopharma company. The Item 8.01 disclosure explicitly states "On August 3, 2026, Supernus Pharmaceuticals, Inc. published a post relating to the proposed merger of equals of the Company and Indivior Pharmaceuticals Inc." This is a material acquisition/merger transaction that would substantially affect the registrant's business, capital structure, and shareholder value, with expected closing in Q4 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-03
Item 8.01
Reformation Inc. completed its initial public offering on July 31, 2026, issuing 14,062,500 shares at $15.00 per share and raising approximately $210.9 million in gross proceeds, marking the company's transition to public markets.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Lafayette Square USA, Inc. disclosed financial and performance information for the fiscal quarter ended June 30, 2026 via an investor presentation filed as Exhibit 99.1 under Item 2.02. The presentation includes consolidated statements of assets and liabilities, consolidated statements of operations for the three and six months ended June 30, 2026 and 2025, key performance metrics (total assets of $1.2B, NAV per share of $14.49, net investment income per share of $0.34 for Q2 2026), and per-share data including earnings per share and dividends declared. This is a standard quarterly earnings disclosure for a BDC.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-08-03
EX-99.1
The exhibit discloses completion of a material asset and liability transfer by Itaú Unibanco's subsidiary (Banco Itaú Colombia) to Banco de Bogotá, involving approximately BRL 9.7 billion in loan portfolio and BRL 7.2 billion in deposits with a net transaction value of BRL 2.5 billion. This constitutes a disposition of a significant portion of the subsidiary's retail banking operations, which is a material M&A activity requiring disclosure under Item 1.02 (Completion of Acquisition or Disposition of Assets).
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-08-03
EX-99.1
The press release announces the appointment of Michael J. Loparco as an independent non-executive director effective August 3, 2026. While the exhibit also discloses a proposed U.S. redomiciliation, the principal disclosed action is the director appointment. Loparco's extensive executive background (CEO of Symbotic and Jabil, current CEO of OrcaWorcs.ai, board member of Sanmina) and relevance to IperionX's manufacturing scale-up make this material to investors assessing board composition and governance capability.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-03
Item 7.01
The disclosure announces a positive clinical safety update for RP-A501 in a Phase 2 trial for Danon disease, reporting that initial three patients were treated safely with no thrombotic microangiopathy or capillary leak syndrome observed. This is a material clinical development milestone for a gene therapy program, but it does not fit neatly into earnings, M&A, impairment, or other specific event categories. The event is clearly operational/strategic in nature—a clinical trial progress update—making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Legal Other
confidence 75%
filed 2026-08-03
Item 7.01
The disclosure reports a Federal Court of Australia order granting relief for an "inadvertent administrative oversight relating to the late lodgement of a cleansing notice" under the Corporations Act. The court orders retroactively validate the issuance and sale of 44,068 CHESS Depositary Interests and relieve sellers from civil liability for non-compliance with disclosure obligations. This is a legal/regulatory event involving securities law compliance and court relief that does not fit the specific categories of litigation, material litigation, or regulatory investigation—it is a favorable court order resolving a technical compliance matter. The materiality is high because it affects the validity of a securities issuance and removes legal exposure for the company and sellers.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This exhibit is a press release announcing Grupo TMM's second quarter 2026 financial results, dated July 31, 2026. It discloses revenue of Ps.261.1 million, operating income of Ps.26.3 million, and net income of Ps.34.3 million for Q2 2026, along with complete balance sheet, income statement, and cash flow statements. The document explicitly states "GRUPO TMM REPORTS SECOND QUARTER 2026 RESULTS" and includes management commentary on operating performance and outlook, which is characteristic of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This Item 5.07 discloses the results of a special meeting of stockholders held on August 3, 2026, where shareholders voted on a merger proposal (adoption of the Merger Agreement with Gaia Purchaser, Inc.) and an advisory compensation proposal. The Merger Proposal was approved with overwhelming support (495,937,250 votes for vs. 74,615 against), representing a material acquisition/change of control event. The disclosure of shareholder vote results on a merger is a core shareholder_vote_results event and is material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
New Jersey Resources issued a press release on August 3, 2026 reporting financial results for the third fiscal quarter ended June 30, 2026, with consolidated net income of $9.7 million ($0.10 per share) and year-to-date net income of $3.48 per share, along with tightened fiscal 2026 NFEPS guidance of $3.52–$3.62.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-08-03
Item 1.01
Nuwellis completed a registered direct offering on August 3, 2026, issuing 1,310,890 shares of common stock at $2.59 per share, generating approximately $3.4 million in gross proceeds, with concurrent private placement of warrants to purchase an equal number of shares at the same exercise price. The offering materially dilutes existing shareholders and increases the company's share count and capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-03
Item 2.02
ON Semiconductor announced its second quarter 2026 financial results on August 3, 2026, disclosing revenue of $1,603.5 million (9% YoY growth), GAAP diluted EPS of $0.56, and non-GAAP diluted EPS of $0.74, along with detailed financial statements and forward guidance for Q3 2026. This is a standard quarterly earnings release filed under Item 2.02 with the earnings press release attached as Exhibit 99.1.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This is a press release announcing unaudited financial results for Q2 2026 and the six-month period ended June 30, 2026. The document discloses Q2 2026 Adjusted Net Income of $9.8 million ($0.40 per share), Net Income of $5.2 million ($0.21 per share), liquidity of $331.5 million, and operational updates including a vessel sale agreement and completion of the Cargill transaction. The disclosure includes financial highlights, a financial summary table with voyage revenue and earnings per share, and reconciliation of non-GAAP measures, all characteristic of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Integer Holdings issued a press release on August 3, 2026 announcing its second quarter 2026 financial results for the period ended July 3, 2026. The disclosure includes detailed quarterly financial metrics (sales, operating income, net income, EPS, EBITDA, and adjusted measures), product line performance, and year-to-date comparisons. This is a standard earnings release disclosure under Item 2.02, with the press release furnished as Exhibit 99.1. While the filing also mentions a pending KKR acquisition, the Item 2.02 section itself is focused on the quarterly earnings announcement.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-08-03
EX-99.1
The press release announces the completion of Brookfield's acquisition of Oaktree, a major credit manager. The disclosure explicitly states "Brookfield today announced that it has completed its acquisition of Oaktree" and describes the transaction as strengthening Brookfield's $365B credit platform. This is a material M&A completion event that would significantly affect a reasonable investor's assessment of the registrant's strategic position and asset base.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-03
Item 5.02
John B. Eagan was appointed as General Counsel and Corporate Secretary effective August 1, 2026, succeeding Wm. Gordon Prescott who retired July 31, 2026. Eagan will oversee all legal affairs and serve on the Executive Management Committee.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-08-03
Item 8.01
The Board adopted an 'Equity Award Treatment upon Retirement Policy' (Good Leaver Policy) on July 29, 2026, establishing compensatory arrangements for Management Committee members and key employees regarding continued vesting of equity awards upon retirement.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-08-03
EX-99.1
Golar LNG announces successful closing of a new $600 million senior secured Revolving Credit Facility. This is a creation of a new direct financial obligation — a credit facility — which falls squarely under debt_issuance. The facility is material to the company's balance sheet flexibility and capital structure, secured by the MKII FLNG asset and backed by a consortium of major banks (ABN AMRO, Citibank, Danske Bank, Standard Chartered).
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-03
EX-99.1
The press release announces the appointment of two new directors to POET's Board of Directors effective August 1, 2026: Dr. Bardia Pezeshki and Jean F. Rankin. Both appointments are described with detailed biographical information highlighting their relevant expertise in technology, optical communications, governance, and corporate transactions. While the exhibit also discloses Jean-Louis Malinge's resignation, the principal disclosed action is the two director appointments, which would materially affect investor assessment of board composition and governance.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-08-03
EX-99.1
Anthony Giovinazzo, who served as chairman of the board of directors, is stepping down from the board "for personal reasons and to pursue other interests." This is a clear departure of a director and board chairman, a governance event material to investors assessing leadership continuity and board composition at a late-stage clinical pharmaceutical company.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-03
The 6-K discloses the results of InMode Ltd.'s Annual General Meeting of Shareholders held on July 30, 2026, reporting that all four proposals were approved: re-election of Dr. Hadar Ron as a Class I director, re-appointment of Kesselman & Kesselman as independent auditors, approval of 6,000 RSUs to non-executive directors, and approval of Special Committee compensation terms. This is a direct disclosure of shareholder vote results under Item 5.07 equivalent, with quorum confirmation (54.71% attendance) and explicit statement that each proposal "was approved."
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This exhibit is a press release announcing Compugen's second quarter 2026 financial results, including revenues of $2.6 million, R&D expenses of $6.3 million, and a net loss of $7.0 million ($0.07 per share). The document explicitly states "Compugen Reports Second Quarter 2026 Results" and includes condensed consolidated statements of operations and balance sheet data for the periods ended June 30, 2026 and 2025. This is a discrete earnings announcement, not a periodic financial report filing, and is material to investors assessing the company's financial performance and cash runway into 2029.
View raw filing on EDGAR →
6-K
Auditor Change
confidence 95%
filed 2026-08-03
EX-99.1
The exhibit is a letter from Somekh Chaikin (a KPMG member firm), the former principal accountant for Nexxen International Ltd., stating that they "were dismissed" on July 29, 2026, after having reported on consolidated financial statements dated March 4, 2026. This is a clear auditor change disclosure required under Item 4.01 of Form 8-K (and analogous 6-K disclosure). The dismissal of an independent auditor is material to investors' assessment of financial reporting reliability.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-03
EX-99.1
This press release announces that QTREX's proprietary quantum interconnect platform has exceeded RF performance requirements established by strategic partners during a qualification process. The disclosure describes a technical validation milestone—successful characterization of the platform's performance across critical parameters (broadband transmission, isolation, timing precision, manufacturing consistency)—and states this "removes a critical technical barrier and validates the readiness of our proprietary platform for commercial application development." While not a discrete M&A, financing, or governance event, this is a material operational/product milestone that advances the company's commercialization program and is expected to strengthen existing strategic engagements in the quantum computing market.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-03
EX-99.1
ParaZero announced receipt of an initial order for DefendAir Net Pods from a Tier-1 European defense manufacturer for integration into an autonomous Counter-UAS system. This represents a material operational and commercial milestone—a significant customer order from an established defense manufacturer that validates the company's technology and expands its market reach. While not a discrete M&A transaction, earnings release, or other named event type, this customer order announcement is clearly material to investors assessing the company's commercial traction and revenue prospects in the Counter-UAS market.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-08-03
The Company entered into consultancy service agreements on August 3, 2026, pursuant to which it agreed to issue 250,000 Class A ordinary shares to each of two unaffiliated third parties (500,000 shares total) as consideration for strategic advisory and consulting services. The shares are being issued as restricted securities under Regulation S, representing a dilutive equity issuance to raise advisory services rather than cash. This is a material capital event affecting shareholder equity and voting power.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 85%
filed 2026-08-03
The Company adopted a 2026 equity incentive plan on August 3, 2026, with 425,000 Class A ordinary shares available for issuance to directors, consultants, and key employees. This is a compensatory arrangement that links employee interests to shareholder value and would materially affect investor assessment of capital structure and dilution risk.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-03
Item 7.01
The filing discloses a declaration of distributions to shareholders across four classes of common shares (Class I, F, A, and E) with specific per-share amounts ranging from $0.1336 to $0.1546 gross, payable on or about August 10, 2026. This is a routine but material dividend distribution event typical of REITs and closed-end funds, disclosed under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-03
Item 8.01
Flutter Entertainment announced the completion of cancellation of its secondary listing on the London Stock Exchange effective August 3, 2026, with shares now trading only on the NYSE. This is a delisting event—the removal of the company's shares from a major exchange listing. While the company maintains its primary NYSE listing and this is an orderly, planned delisting rather than a forced one, it materially affects the trading venues available to shareholders and represents a significant change in the company's listing status.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-08-03
This is a Consolidated Summary Report for the three months ended June 30, 2026, containing quarterly consolidated financial statements (balance sheet, income statement, comprehensive income statement) prepared under Japanese GAAP. The document explicitly states it is a "Consolidated Summary Report" for "the three months ended June 30, 2026" and includes full consolidated financial statements and notes. This is a periodic quarterly financial report itself, not a discrete event or earnings press release.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-08-03
This exhibit is Nomura Holdings' consolidated financial results for the first quarter of fiscal year ending March 2027 (FY2026/27 1Q), presented as a financial supplement with detailed segment breakdowns, KPIs, and operational metrics. The document is explicitly titled "Consolidated Results of Operations First quarter, year ending March 2027 (US GAAP)" and contains comprehensive quarterly financial statements and analysis, making it a periodic quarterly financial report rather than a discrete earnings-release event.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.1
This exhibit is a press release announcing MakeMyTrip's unaudited interim financial and operating results for fiscal 2027 first quarter ended June 30, 2026. It discloses revenue of $285.6 million (up 6.2% YoY, 16.1% in constant currency), profit for the period of $9.1 million (down 64.7% YoY), and detailed segment performance across air ticketing, hotels and packages, bus ticketing, and other services. The document includes comprehensive financial tables, segment analysis, and management discussion of results drivers. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-08-03
Item 8.01
This disclosure describes a major operational disruption caused by wildfires in Avista's service territory, resulting in extensive damage to transmission and distribution infrastructure, widespread customer outages affecting thousands of customers, and significant restoration efforts underway. While the event involves operational impacts and potential financial consequences (infrastructure damage, restoration costs), it does not fit the specific categories of material_impairment (no accounting charge disclosed), workforce_reduction, or other named types. The core event is an operational crisis affecting service delivery and infrastructure, making operational_other the most appropriate classification.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-08-03
The 6-K discloses completion of a share repurchase program (10.4 million shares for JPY 71.5 billion in July 2026) and announcement of cancellation of 28.0 million shares scheduled for August 20, 2026. Share repurchases and cancellations constitute a return of capital to shareholders and are classified as dividend_distribution events. The materiality is evident from the scale (0.7% of issued shares cancelled, JPY 180 billion authorized program) and impact on shareholder equity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
American Bitcoin Corp. issued a press release on August 3, 2026, announcing its financial results for the second quarter ended June 30, 2026, including revenue of $67.0 million, mining production of ~932 Bitcoin (record quarterly production), and strategic reserve growth to over 8,000 Bitcoin. The filing explicitly discloses this under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases on Form 8-K.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-08-03
Item 1.01
Indivior entered into an Agreement and Plan of Merger dated August 1, 2026, with Supernus Pharmaceuticals, whereby Supernus will merge into Indivior's subsidiary Artemis Merger Sub, with Supernus as the surviving company and wholly owned subsidiary of Indivior. The transaction involves a stock-for-stock exchange (1.5401 Indivior shares per Supernus share), a $1 billion special dividend to Indivior shareholders, and a $650 million debt commitment, with the combined company to be renamed Supernus, Inc., and post-closing ownership of approximately 56.5% by Indivior shareholders and 43.5% by Supernus shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Indivior issued a press release on August 3, 2026 reporting Q2 2026 financial results for the period ended June 30, 2026, with total net revenue of $343 million (up 14% YoY), record SUBLOCADE net revenue of $253 million (up 21% YoY), record GAAP net income of $122 million, and record adjusted EBITDA of $186 million (up 111% YoY), along with raised full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-03
Item 1.01
Autolus entered into a Note Purchase Agreement with Perceptive on July 30, 2026, creating a senior secured notes facility of up to $250 million, with an initial $75 million tranche issued on the Closing Date. The facility includes financial covenants (minimum liquidity and revenue thresholds) and security interests in substantially all assets.
View raw filing on EDGAR →